Pursuant to RCW 18.53.010(3) the optometry board adopts the following drug formulary of topically applied drugs administered for diagnosis, treatment, or mitigation purposes.

1. (1) Drugs for diagnostic or therapeutic purposes.

   1. (a) Mydriatics.
   2. (b) Cycloplegics.
   3. (c) Miotics.
   4. (d) Anesthetics.

2. (2) Drugs for therapeutic purposes only.

   1. (a) Anti-infectives.
   2. (b) Antihistamines and decongestants.
   3. (c) Ocular lubricants.
   4. (d) Antiglaucoma and ocular hypotensives.
   5. (e) Anti-inflammatories.
   6. (f) Hyperosmotics.
   7. (g) Anti-parasitics.
   8. (h) All other topical drugs and compounds used for the diagnosis, treatment or mitigation of conditions of the eye and adnexa approved by the FDA (both on-label and off-label).

[Statutory Authority: RCW 18.53.010 and 18.54.070. WSR 24-23-044, s 246-851-410, filed 11/14/24, effective 12/15/24. Statutory Authority: RCW 18.54.070. WSR 91-06-025 (Order 119B), recodified as § 246-851-410, filed 2/26/91, effective 3/29/91. Statutory Authority: RCW 18.53.010. WSR 89-17-040 (Order PM 853), § 308-53-340, filed 8/11/89, effective 9/11/89.]